Characterisation of KRAS mutations in patients with metastatic colorectal cancer: A single institution experience

被引：0

作者：

Alameda, M. ^{[1
]}

Rueda-Lara, A. ^{[1
]}

Vinal, D. ^{[1
]}

Contreras, P. Zwisler ^{[1
]}

Martin-Montalvo, G. ^{[1
]}

Ruiz-Gutierrez, I. ^{[1
]}

Pena, J. ^{[1
]}

Jimenez-Bou, D. ^{[1
]}

Perez, D. Martinez ^{[1
]}

Barbas, J. Pedregosa ^{[1
]}

Garcia-Cuesta, J. ^{[1
]}

Rodriguez-Salas, N. ^{[1
]}

Feliu, J. ^{[1
]}

Rios, M. ^{[2
]}

Mendiola, M. ^{[1
]}

机构：

[1] Hosp Univ La Paz, Madrid, Spain

[2] Autonomous Univ Madrid, Madrid, Spain

来源：

ANNALS OF ONCOLOGY | 2023年 / 34卷

关键词：

D O I：

10.1016/j.annonc.2023.04.298

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P-242

引用

页码：S101 / S101

页数：1

共 50 条

[21] KRAS mutations in patients with colorectal cancer in Libya
Abudabous, Asma
Drah, Mustafa
Aldehmani, Mamdouh
Parker, Iqbal
Alqawi, Omar
MOLECULAR AND CLINICAL ONCOLOGY, 2021, 15 (04)
[22] SURVIVAL IMPACT OF THE INTRODUCTION OF OXALIPLATIN AND IRINOTECAN IN THE TREATMENT OF PATIENTS WITH METASTATIC COLORECTAL CANCER: A SINGLE INSTITUTION EXPERIENCE
Oliveira, M.
Dionisio, M.
Esteves, S.
Oliveira, J.
Moreira, A.
ANNALS OF ONCOLOGY, 2010, 21 : 62 - 63
[23] Prognostic value of skeletal muscle area at diagnosis in patients with metastatic colorectal cancer: A single institution experience
Rios, M.
Vinal, D.
Rueda-Lara, A.
Alameda, M.
Martin-Montalvo, G.
Rodriguez-Salas, N.
Feliu, J.
ANNALS OF ONCOLOGY, 2023, 34 : S94 - S94
[24] Detection of KRAS mutations in circulating tumor cells from patients with metastatic colorectal cancer
Buim, Marcilei E. C.
Fanelli, Marcello F.
Souza, Virgilio S.
Romero, Juliana
Abdallah, Emne A.
Mello, Celso A. L.
Alves, Vanessa
Ocea, Luciana M. M.
Mingues, Natalia B.
Barbosa, Paula N. V. P.
Tyng, Chiang J.
Chojniak, Rubens
Chinen, Ludmilla T. D.
CANCER BIOLOGY & THERAPY, 2015, 16 (09) : 1289 - 1295
[25] Lack of Relationship Between Clinical Features and KRAS Mutations in Patients with Metastatic Colorectal Cancer
Ploquin, Anne
Zerimech, Farid
Escande, Fabienne
Adenis, Antoine
Giraud, Claire
Gasnault, Laurent
Bourgeois, Vincent
Desauw, Christophe
Hebbar, Mohamed
ANTICANCER RESEARCH, 2016, 36 (08) : 4233 - 4236
[26] Cetuximab Might Be Detrimental to Metastatic Colorectal Cancer Patients with KRAS Codon 12 Mutations
Liang, Yi-Hsin
Lin, Yu-Lin
Liau, Jau-Yu
Tsai, Jia-Huei
Liang, Jin-Tung
Lin, Been-Ren
Hung, Ji-Shiang
Tseng, Li-Hui
Lin, Liang-In
Chang, Yih-Leong
Cheng, Ann-Lii
Yeh, Kun-Huei
ANTICANCER RESEARCH, 2015, 35 (07) : 4207 - 4214
[27] ACTIVATING KRAS MUTATIONS AS AN INDEPENDENT PREDICTOR IN METASTATIC COLORECTAL CANCER PATIENTS TREATED WITH CETUXIMAB
Lin, O. S. R.
ANNALS OF ONCOLOGY, 2010, 21 : I36 - I36
[28] Mutations of KRAS/NRAS/BRAF predict cetuximab resistance in metastatic colorectal cancer patients
Hsu, Hung-Chih
Thiam, Tan Kien
Lu, Yen-Jung
Yeh, Chien Yuh
Tsai, Wen-Sy
You, Jeng Fu
Hung, Hsin Yuan
Tsai, Chi-Neu
Hsu, An
Chen, Hua-Chien
Chen, Shu-Jen
Yang, Tsai Sheng
ONCOTARGET, 2016, 7 (16) : 22257 - 22270
[29] The impact of KRAS mutations on risk of venous thromboembolism recurrence in patients with metastatic colorectal cancer
Zhikun Liang
Xiaoyan Huang
Jieling Mao
Jingwen Xie
Xiaoyan Li
Li Qin
BMC Gastroenterology, 25 (1)
[30] Distinct impacts of KRAS, NRAS and BRAF mutations on survival of patients with metastatic colorectal cancer
Wang, Yucai
Loree, Jonathan M.
Yu, Cecilia
Tschautscher, Marcella
Briggler, Andrew M.
Overman, Michael J.
Broaddus, Russell
Meric-Bernstam, Funda
Jones, Jeremy Clifton
Balcom, Jessica
Kipp, Benjamin
Kopetz, Scott
Grothey, Axel
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)

← 1 2 3 4 5 →